How acetylcholine controls emotional memory circuits in the amygdala
Cholinergic regulation of amygdalar circuits in emotional memory
This work looks at how the brain chemical acetylcholine influences emotion and memory circuits in people with anxiety and Alzheimer-type memory problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-11311284 on NIH RePORTER |
What this research studies
From a patient's point of view, the team is exploring how acetylcholine, a brain chemical, helps coordinate nerve cells and rhythms in the amygdala and connected frontal brain regions that drive fear and emotional memories. They will record and manipulate neural activity and the cholinergic system to see how these rhythms support learning and fear responses. The goal is to uncover why these circuits go wrong in anxiety and memory disorders by studying rhythm patterns and specific cell types. Findings will guide ideas for treatments that could restore healthy brain rhythms and emotional memory processing.
Who could benefit from this research
Good fit: Adults with anxiety disorders or Alzheimer-type dementia who have troubling fear responses or emotional memory problems could be the eventual focus of related clinical work.
Not a fit: People without anxiety or memory-related symptoms, or those needing immediate clinical care, are unlikely to get direct benefit from this basic lab-focused research right away.
Why it matters
Potential benefit: If successful, this work could point to new treatment targets to reduce persistent fear and improve emotional memory in anxiety and Alzheimer-related conditions.
How similar studies have performed: Previous studies support a role for acetylcholine in emotional learning and brain rhythm coordination, but the exact circuit mechanisms targeted here remain largely untested.
Where this research is happening
Columbia, United States
- University of South Carolina at Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Mott, David D — University of South Carolina at Columbia
- Study coordinator: Mott, David D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.